Skip to main content
. Author manuscript; available in PMC: 2019 Aug 3.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2018 Aug 3;14(8):817–829. doi: 10.1080/17425255.2018.1499726

Table 2.

A few examples of the estimated fractions of drug transported by P-gp or BCRP across the placenta

Compound Species Transporter Ft Reference
Glyburide Human BCRP 0.43 [91]
D-luciferin Mouse Bcrp 0.67 [137]
Digoxin Mouse P-gp 0.58 [56]
Saquinavir Mouse P-gp 0.86 [56]
Paclitaxel Mouse P-gp 0.94 [56]
L-652,280 Mouse P-gp 0.87 [57]
Lopinavir Mouse P-gp 0.5 [51]
Norbuprenorphine Mouse P-gp 0 [61]
Nitrofurantoin Mouse Bcrp 0.75 [95]
Glyburide Mouse Bcrp 0.50 [96]
Cyclosporine Rat P-gp 0.41 [138]
Tenofovir Rat Bcrp 0.33 [92]

Ft values of drugs in mice were estimated using Equation 3 with data in P-gp or Bcrp KO and WT mice. Ft values of drugs in humans or rats were estimated using Equation 4 with placental perfusion data in the presence and absence of an inhibitor. In all the calculations, total plasma or perfusate concentrations or AUCs were used, assuming that that the plasma protein binding of drugs remains the same across the placental barrier.